Literature DB >> 25941550

Fibroblast Growth Factor Receptor 3 (FGF-R3): A Promising Therapeutic Target for the Treatment of Bladder Cancer.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2015        PMID： 25941550      PMCID： PMC4416439          DOI： 10.1021/acsmedchemlett.5b00078

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

Review 1.  Targeted therapies in urothelial carcinoma.

Authors:  Monalisa Ghosh; Sam J Brancato; Piyush K Agarwal; Andrea B Apolo
Journal:  Curr Opin Oncol       Date:  2014-05       Impact factor: 3.645

Review 2.  Fibroblast growth factor receptor-3 in urothelial tumorigenesis.

Authors:  Gopa Iyer; Matthew I Milowsky
Journal:  Urol Oncol       Date:  2012-01-30       Impact factor: 3.498

Review 3.  Review of the recently defined molecular mechanisms underlying thanatophoric dysplasia and their potential therapeutic implications for achondroplasia.

Authors:  María Luisa Martínez-Frías; Cristina A de Frutos; Eva Bermejo; M Angela Nieto
Journal:  Am J Med Genet A       Date:  2010-01       Impact factor: 2.802
  3 in total
  2 in total

1.  Synthesis of 3,6-diaryl-1H-pyrazolo[3,4-b]pyridines via one-pot sequential Suzuki-Miyaura coupling.

Authors:  Vibha Tandon; Parthasarathi Das; S Kukreti
Journal:  RSC Adv       Date:  2018-10-11       Impact factor: 3.361

2.  Comprehensive FGFR3 alteration-related transcriptomic characterization is involved in immune infiltration and correlated with prognosis and immunotherapy response of bladder cancer.

Authors:  Ting Xu; Weizhang Xu; Yuxiao Zheng; Xiao Li; Hongzhou Cai; Zicheng Xu; Qing Zou; Bin Yu
Journal:  Front Immunol       Date:  2022-07-26       Impact factor: 8.786
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.